Skip to main content
. 2021 May 4;23(10):2141–2154. doi: 10.1007/s12094-021-02621-w

Fig. 4.

Fig. 4

Genes from the 42-gene low-response signature have prognostic value in pediatric AML. a, b Two genes encoding respiratory chain complex I subunits, NDUFA3 and NDUFA6, demonstrated significantly worse EFS for patients with expression levels in the highest quartile (Q4), compared to those with lower expression. c Patients with expression of the signaling regulator CAVIN3 in the highest quartile (Q4) had significantly lower EFS than those in quartiles 1–3. d Patients with expression of the HIF1α target ANKRD37 in quartiles 2–4 had significantly inferior outcomes compared to patients with expression in the lowest quartile (Q1). Kaplan–Meier estimates are based on clinically annotated RNA-seq data for 1061 patients in the TpAML dataset. Log-rank p-values are shown